SEC 13F Intelligence

Skandinaviska Enskilda Banken AB (Publ) / DGX

Skandinaviska Enskilda Banken AB (Publ)’s Quest Diagnostics Inc Position

Does Skandinaviska Enskilda Banken AB (Publ) own Quest Diagnostics Inc (DGX)? Not currently — the last reported position was 139.9K shares worth $24M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$24M
Q4 2025
Shares
139.9K
% of Portfolio
+0.10%
Quarters Held
29
position exited

Position History DGX

Reported value by quarter
Q4 ’18: $27MQ4 ’18Q1 ’19: $8MQ2 ’19: $5MQ3 ’19: $5MQ4 ’19: $4MQ4 ’19Q1 ’20: $3MQ2 ’20: $42MQ3 ’20: $46MQ4 ’20: $64MQ4 ’20Q1 ’21: $47MQ2 ’21: $57MQ3 ’21: $79MQ4 ’21: $73MQ4 ’21Q1 ’22: $46MQ2 ’22: $26MQ3 ’22: $20MQ4 ’22: $28MQ4 ’22Q1 ’23: $24MQ2 ’23: $23MQ3 ’23: $17MQ4 ’23: $18MQ4 ’23Q1 ’24: $27MQ2 ’24: $3MQ3 ’24: $4MQ4 ’24: $4MQ4 ’24Q1 ’25: $23MQ2 ’25: $34MQ3 ’25: $31MQ4 ’25: $24MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025139.9K$24M+0.10%
Q3 2025161.9K$31M+0.12%
Q2 2025189.2K$34M+0.15%
Q1 2025133.1K$23M+0.11%
Q4 202426.0K$4M+0.02%
Q3 202423.1K$4M+0.02%
Q2 202423.1K$3M+0.02%
Q1 2024200.9K$27M+0.13%
Q4 2023128.9K$18M+0.10%
Q3 2023136.8K$17M+0.11%
Q2 2023163.0K$23M+0.15%
Q1 2023168.6K$24M+0.17%
Q4 2022178.3K$28M+0.21%
Q3 2022159.3K$20M+0.15%
Q2 2022199.1K$26M+0.19%
Q1 2022335.7K$46M+0.27%
Q4 2021424.6K$73M+0.37%
Q3 2021547.1K$79M+0.44%
Q2 2021433.8K$57M+0.35%
Q1 2021367.0K$47M+0.31%
Q4 2020540.9K$64M+0.44%
Q3 2020397.9K$46M+0.33%
Q2 2020364.2K$42M+0.34%
Q1 202039.2K$3M+0.03%
Q4 201936.9K$4M+0.03%
Q3 201950.2K$5M+0.05%
Q2 201949.4K$5M+0.04%
Q1 201983.6K$8M+0.07%
Q4 2018328.6K$27M+0.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of DGX.